Biofrontera
NASDAQ: BFRIWoburn, US · Founded 2015 · Delaware corporation · 80 employees on LinkedIn
Biofrontera develops treatments for actinic keratosis and other common skin conditions, aimed at improving outcomes for dermatology patients and providers. The company operates in the pharmaceutical and dermatology space.
Founders & leadership
Biofrontera was founded in 2015 by Hermann Luebbert.
HL
Hermann LuebbertinFounder · CEOformer
EF
Eugene Frederick Leffler, IIIExecutive
EF
Erica F GatesNamed on SEC filing
JJ
John J III BorerNamed on SEC filing
LM
Loretta M WedgeNamed on SEC filing
EL
Erica L MonacoNamed on SEC filing
Board
JJ
John J. Borer IIIBoard director
BH
Beth HoffmanBoard director
HL
Heikki LanckrietBoard director
KD
Kevin D. WeberBoard director
Reported raises · per SEC filings
Form D private placements$58.4M disclosed across 7 rounds · 2021–2025
▶$11MraisedJul 2025 · 5 investors · PharmaceuticalsRule 506(b)
▶$11MraisedJul 2025 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Beth HoffmanDirector
- John J. Borer IIIDirector
- Hermann LuebbertExecutive Officer, Director
- Eugene Frederick Leffler, IIIExecutive Officer
- Heikki LanckrietDirector
- Kevin D. WeberDirector
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.2MraisedDec 2024 · 5 investors · PharmaceuticalsRule 506(b)
▶$4.2MraisedDec 2024 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John J. Borer IIIDirector
- Beth HoffmanDirector
- Hermann LuebbertExecutive Officer, Director
- Heikki LanckrietDirector
- Eugene Frederick Leffler, IIIExecutive Officer
- Kevin D. WeberDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedMar 2024 · 8 investors · PharmaceuticalsRule 506(b)
▶$8MraisedMar 2024 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin D. WeberDirector
- John J. Borer IIIDirector
- Eugene Frederick Leffler, IIIExecutive Officer
- Hermann LuebbertExecutive Officer, Director
- Beth HoffmanDirector
- Heikki LanckrietDirector
- Offering amount
- $8M
- Amount sold
- $8M
- Sales commissions
- $685K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedNov 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$3.7MraisedNov 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John J III BorerDirector
- Kevin D WeberDirector
- Hermann LuebbertExecutive Officer, Director
- Erica F GatesExecutive Officer
- Erica L MonacoExecutive Officer
- Eugene Frederick LefflerExecutive Officer
- Loretta M WedgeDirector
- Beth J HoffmanDirector
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.1MraisedAug 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$7.1MraisedAug 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Erica L MonacoExecutive Officer
- Hermann LuebbertExecutive Officer, Director
- Beth J HoffmanDirector
- Kevin D WeberDirector
- John J III BorerDirector
- Loretta M WedgeDirector
- Erica F GatesExecutive Officer
- Offering amount
- $7.1M
- Amount sold
- $7.1M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.4MraisedMay 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$9.4MraisedMay 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin D WeberDirector
- Loretta M WedgeDirector
- Erica L MonacoExecutive Officer
- Beth J HoffmanDirector
- John J III BorerDirector
- Hermann LuebbertExecutive Officer, Director
- Erica F GatesExecutive Officer
- Offering amount
- $9.4M
- Amount sold
- $9.4M
- Sales commissions
- $660.1K
- Placement agents
- The Benchmark Company, LLC, Roth Capital Partners, LLC
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedDec 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Erica F GatesExecutive Officer
- John J III BorerDirector
- Beth J HoffmanDirector
- Hermann LuebbertExecutive Officer, Director
- Loretta M WedgeDirector
- Erica L MonacoExecutive Officer
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $1.2M
- Placement agents
- Roth Capital Partners, LLC, The Benchmark Company, LLC
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapTipRanks9 shared keywordsFinancial analysis and stock research platform.
Simply Wall St8 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Public7 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Seeking Alpha7 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
TradingView7 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Robinhood7 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwits6 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Companies competing with Biofrontera for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Biofrontera do?
- Biofrontera develops treatments for actinic keratosis and other common skin conditions, aimed at improving outcomes for dermatology patients and providers. The company operates in the pharmaceutical and dermatology space.
- Who founded Biofrontera?
- Biofrontera was founded by Hermann Luebbert in 2015.
- How much funding has Biofrontera raised?
- Biofrontera has disclosed $58.4M raised across 7 rounds.
- Where is Biofrontera headquartered?
- Biofrontera is headquartered in Woburn, US.